Rajkot News Today

Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight

 Breaking News
  • No posts were found

Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight

April 27
04:16 2022
Angioedema Market, Epidemiology, Treatment, Pipeline, Drugs, Companies and Competitive Analysis by DelveInsight
Angioedema Market

Angioedema is swelling underneath the skin. It’s usually a reaction to a trigger, such as a medicine or something you’re allergic to. It is not normally serious, but it can be a recurring problem for some people and can very occasionally be life-threatening if it affects breathing.

 

DelveInsight’s Angioedema Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Angioedema, historical and forecasted epidemiology as well as the Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of Angioedema Market Report are:

  • HAE in the US has been observed with the maximum number of diagnosed cases in the age-group 17 to below 65 years, followed by those who belong to the age-group 12 to less than 17 years. DelveInsight’s analysts have estimated that there were 882 cases diagnosed for the age group 17 to below 65 years in 2017, among the US population, which is predicted to increase consistently throughout the study period.
  • Among the European countries, France had the highest prevalent population of 1,346 cases, followed by the UK which had prevalent population of 1,301 in 2017.
  • Type 1 HAE (98.73%) accounted for the majority of Chinese HAE patients, while no type 3 HAE patient has been diagnosed in China to date (Liu et al, 2019).
  • According to DelveInsight’s analysis, HAE is more prominent in females in comparison to males.

 

To know more details about Angioedema Market Report, Click here: https://www.delveinsight.com/sample-request/angioedema-market

 

Scope of the Angioedema Market Report

  • The report covers the descriptive overview of Angioedema, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Angioedema epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Angioedema is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of the Angioedema market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Angioedema market

 

To know more details of Angioedema Market Report, Click here: https://www.delveinsight.com/report-store/angioedema-market

 

Some of Angioedema Drugs are:

  • Lanadelumab
  • C1 inhibitor concentrate (C1-esteraseremmer-N)
  • Icatibant
  • Omalizumab
  • KVD824
  • And Many Others

 

Some of the Angioedema Companies are:

  • Takeda
  • Shire Pharmaceuticals
  • Prothya Biosolutions
  • Novartis
  • KalVista Pharmaceuticals
  • And Many Others

 

To know more details about Angioedema Pipeline drugs and Therapies, Click here: https://www.delveinsight.com/sample-request/angioedema-market

 

Table of Contents:

1. Key Insights

2. Executive Summary of Angioedema

3. Competitive Intelligence Analysis for Angioedema

4. Angioedema: Market Overview at a Glance

5. Angioedema: Disease Background and Overview

6. Patient Journey

7. Angioedema Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Angioedema Unmet Needs

10. Key Endpoints of Angioedema Treatment

11. Angioedema Marketed Products

12. Angioedema Emerging Therapies

13. Angioedema: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Angioedema

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/angioedema-market

Related Articles